Literature DB >> 9609627

Sixty adrenal masses of large dimensions: hormonal and morphologic evaluation.

G P Bernini1, P Miccoli, A Moretti, M S Vivaldi, P Iacconi, A Salvetti.   

Abstract

OBJECTIVES: To evaluate the nature and function of adrenal masses of large dimensions (macrotumors).
METHODS: Sixty consecutive patients (31 women, 29 men, age range 15 to 84 years) with adrenal masses 4.0 cm in diameter or larger (range 4.0 to 15.0 cm) underwent morphologic study by computed tomography (CT); the majority also underwent 131-I-6beta-norcholesterol (131I-NC) or 131I-MIBG scintigraphy. Basal evaluation of glucocorticoids, mineralcorticoids, and catecholamines was performed in all patients, and in 38 cases determination of androgens was also made. In addition, on the basis of various clinical suspicions, a dynamic hormonal study was performed.
RESULTS: Macrotumors were benign in 78.3% of cases and included pheochromocytomas (n = 17), nonfunctioning cortical adenomas (n = 12), and cortisol-secreting tumors (n = 7, Cushing's syndrome). Malignant forms were 21.7% of the total, including pheochromocytomas (n = 3), cortical carcinomas (n = 6), and metastases (n = 4). On CT, malignant masses were larger (8.4+/-0.9 cm) than benign ones (5.7+/-0.3 cm) (P < 0.0001) and the mass size was strictly related to malignancy (P < 0.03). CT did not offer other diagnostic criteria for malignancy, except irregular margins and regional lymph node enlargement, which were more frequently (P < 0.0001) found in malignant forms. 131I-MIBG scintigraphy showed tracer uptake in all pheochromocytomas, both benign and malignant. By contrast, on 131I-NC scintigraphy, cortical malignancies never accumulated the radiotracer, whereas uptake was observed in all cases of solid cortical benign adenomas. Patients with cortical carcinomas showed plasma sex steroids above the normal range, pheochromocytomas were asymptomatic in 15% of cases, and almost half of the patients with Cushing's syndrome did not show clinical features of the disease (pre-Cushing's syndrome).
CONCLUSIONS: Adrenal macrotumors frequently show endocrine activity and the medulla seems to be involved more than the cortex. Pheochromocytomas and cortisol-secreting adenomas are sometimes asymptomatic. Malignancy is often found in macromasses and, at least for the cortical forms, size of the tumor on CT, 131I-NC uptake on scintigraphy, and determination of levels of sex steroids seem to be useful criteria for predicting the nature of the mass.

Entities:  

Mesh:

Year:  1998        PMID: 9609627     DOI: 10.1016/s0090-4295(98)00026-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  The adrenal incidentaloma: disease of modern technology and public health problem.

Authors:  D C Aron
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Simultaneous bilateral laparoscopic adrenalectomy is safe for synchronous large adrenal tumors.

Authors:  Giovanni Ramacciato; Paolo Mercantini; Marco La Torre; Nicola De Ruvo; Giorgio Ercolani; Antonio Stigliano; Vincenzo Toscano
Journal:  JSLS       Date:  2006 Jul-Sep       Impact factor: 2.172

3.  Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm?

Authors:  Giovanni Ramacciato; Paolo Mercantini; Marco La Torre; Fabrizio Di Benedetto; Giorgio Ercolani; Matteo Ravaioli; Micaela Piccoli; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2007-08-18       Impact factor: 4.584

4.  The economic implications of unsuspected findings from CT urography performed for haematuria.

Authors:  S J Bromage; M P C Liew; K C Moore; B Raju; D C Shackley
Journal:  Br J Radiol       Date:  2012-05-09       Impact factor: 3.039

Review 5.  Laparoscopic surgery for malignant adrenal tumors.

Authors:  G N Zografos; G Vasiliadis; A N Farfaras; C Aggeli; M Digalakis
Journal:  JSLS       Date:  2009 Apr-Jun       Impact factor: 2.172

6.  Laparoscopic adrenalectomy for adrenal tumors.

Authors:  Sun Chuan-Yu; Ho Yat-Faat; Ding Wei-Hong; Gou Yuan-Cheng; Hu Qing-Feng; Xu Ke; Gu Bin; Xia Guo-Wei
Journal:  Int J Endocrinol       Date:  2014-07-15       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.